Positron emission tomography/computed tomography in melanoma.
Radiol Clin North Am
; 51(5): 865-79, 2013 Sep.
Article
en En
| MEDLINE
| ID: mdl-24010910
Fludeoxyglucose F 18 positron emission tomography/computed tomography (PET/CT) has been invaluable in the assessment of melanoma throughout the course of the disease. As with any modality, the studies are incomplete and more information will be gleaned as our experience progresses. Additionally, it is hoped that a newer PET agent in the pipeline will give us even greater success in the identification and subsequent treatment of melanoma. This article aims to examine the utilization of PET/CT in the staging, prognostication, and follow-up of melanoma while providing the physicians who order and interpret these studies practical guidelines and interpretive pitfalls.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Neoplasias Cutáneas
/
Imagen Multimodal
/
Melanoma
Tipo de estudio:
Guideline
Límite:
Humans
Idioma:
En
Revista:
Radiol Clin North Am
Año:
2013
Tipo del documento:
Article
País de afiliación:
Estados Unidos
Pais de publicación:
Estados Unidos